CENTAVISC Trademark

Trademark Overview

On Friday, January 24, 2025, a trademark application was filed for CENTAVISC with the United States Patent and Trademark Office. The USPTO has given the CENTAVISC trademark a serial number of 99017323. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Friday, June 12, 2026. This trademark is owned by THERAMICRO, LLC. The CENTAVISC trademark is filed in the Pharmaceutical Products category with the following description:

amnio-patches being medical preparations for treating wounds; sterile amniotic allograft being human allograft tissue

General Information

Serial Number99017323
Word MarkCENTAVISC
Filing DateFriday, January 24, 2025
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateFriday, June 12, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 29, 2025

Trademark Statements

Goods and Servicesamnio-patches being medical preparations for treating wounds; sterile amniotic allograft being human allograft tissue

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 24, 2025
Primary Code005
First Use Anywhere DateMonday, March 31, 2025
First Use In Commerce DateMonday, March 31, 2025

Trademark Owner History

Party NameTHERAMICRO, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMemphis, TN 38120
US
Party NameTHERAMICRO, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMemphis, TN 38120
US

Trademark Events

Event DateEvent Description
Friday, January 24, 2025NEW APPLICATION ENTERED
Friday, January 24, 2025APPLICATION FILING RECEIPT MAILED
Friday, January 24, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, March 8, 2025ASSIGNED TO EXAMINER
Monday, March 24, 2025NON-FINAL ACTION WRITTEN
Monday, March 24, 2025NON-FINAL ACTION E-MAILED
Monday, March 24, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 26, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 26, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 26, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 31, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 23, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 29, 2025PUBLISHED FOR OPPOSITION
Tuesday, April 29, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 24, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 19, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 19, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 19, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 22, 2025TEAS STATEMENT OF USE RECEIVED
Saturday, May 9, 2026CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 22, 2025USE AMENDMENT FILED
Saturday, May 9, 2026STATEMENT OF USE PROCESSING COMPLETE
Friday, June 12, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, June 12, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

centavisc allograft being amniotic tissue human sterile treating patches medical preparations